Cargando…
Transcatheter Bioprosthetic Aortic Valve Dysfunction: What We Know So Far
Transcatheter aortic valve replacement (TAVR) is an established alternative to surgical valve replacement for patients with severe aortic stenosis (AS) and increased surgical risk. On the basis of the favorable outcomes of recent randomized clinical trials conducted in intermediate and low risk popu...
Autores principales: | Sawaya, Fadi, Jørgensen, Troels H., Søndergaard, Lars, De Backer, Ole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787554/ https://www.ncbi.nlm.nih.gov/pubmed/31637246 http://dx.doi.org/10.3389/fcvm.2019.00145 |
Ejemplares similares
-
Challenges When Expanding Transcatheter Aortic Valve Implantation to Younger Patients
por: De Backer, Ole, et al.
Publicado: (2018) -
Practical Approach to Transcatheter Aortic Valve Implantation and Bioprosthetic Valve Fracture in a Failed Bioprosthetic Surgical Valve
por: Vanhaverbeke, Maarten, et al.
Publicado: (2022) -
Clinical Valve Thrombosis and Subclinical Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement: Is There a Need for a Patient-Tailored Antithrombotic Therapy?
por: Rosseel, Liesbeth, et al.
Publicado: (2019) -
Transcatheter aortic valve durability: a contemporary clinical review
por: Montarello, Nicholas J., et al.
Publicado: (2023) -
Comparison of middle-term valve durability between transcatheter aortic valve implantation and surgical aortic valve replacement: an updated systematic review and meta-analysis of RCTs
por: Lerman, Tsahi T., et al.
Publicado: (2023)